News Releases

Select year
Categories

Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care

Dec 20, 2023 | Products

Read more

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

Nov 20, 2023 | Products

Read more

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

Nov 16, 2023 | Corporate | Products

Read more

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

Oct 26, 2023 | Products | Corporate

Read more

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

Sep 28, 2023 | Products

Read more

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Sep 19, 2023 | Products

Read more

Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer

Sep 18, 2023 | Products

Read more

New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

Sep 06, 2023 | Products

Read more

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

Aug 22, 2023 | Products

Read more

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Aug 15, 2023 | Products

Read more

Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

Aug 08, 2023 | Products

Read more

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

Aug 07, 2023 | Products

Read more

Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

Jul 24, 2023 | Products

Read more

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Jun 12, 2023 | Products

Read more

Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023

Jun 01, 2023 | Products | Corporate

Read more

Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer

May 24, 2023 | Products

Read more

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey

Apr 19, 2023 | Products

Read more

Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

Apr 18, 2023 | Products

Read more

Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

Apr 12, 2023 | Products | Corporate

Read more

Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

Mar 02, 2023 | Products | Corporate

Read more

Myriad Genetics Applauds New Expanded Carrier Screening Practice Guidelines from NSGC

Mar 01, 2023 | Products

Read more

Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing

Feb 07, 2023 | Products

Read more

Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities

Jan 05, 2023 | Products

Read more